Bcl-2 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bcl-2" in Japanese language version.

refsWebsite

Global rank Japanese rank

100nih.gov

4^th place

24^th place

56doi.org

2^nd place

6^th place

8harvard.edu

18^th place

107^th place

4worldcat.org

5^th place

19^th place

2ensembl.org

1,626^th place

2,625^th place

2wikipedia.org

low place

2web.archive.org

1^st place

2medpagetoday.com

9,274^th place

low place

1univ-montp2.fr

low place

1rcsb.org

8,838^th place

low place

1drugs.com

399^th place

1,603^rd place

1asianscientist.com

low place

1stokesentinel.co.uk

5,309^th place

low place

1fda.gov

447^th place

1,043^rd place

asianscientist.com

Liao, Grace (12 August 2011). “ABT-199 BH-3 Mimetic Enters Phase Ia Trial For Chronic Lymphocytic Leukemia”. Asian Scientist. オリジナルの18 July 2012時点におけるアーカイブ。 11 February 2016閲覧。

doi.org

“Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation”. Science 226 (4678): 1097–9. (Nov 1984). Bibcode: 1984Sci...226.1097T. doi:10.1126/science.6093263. PMID 6093263.
“Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation”. Cell 47 (1): 19–28. (Oct 1986). doi:10.1016/0092-8674(86)90362-4. PMID 2875799.
PDB: 1G5M; “Solution structure of the antiapoptotic protein bcl-2”. Proceedings of the National Academy of Sciences of the United States of America 98 (6): 3012–7. (March 2001). Bibcode: 2001PNAS...98.3012P. doi:10.1073/pnas.041619798. PMC 30598. PMID 11248023.
“Multiple functions of BCL-2 family proteins”. Cold Spring Harb Perspect Biol 5 (2): a008722. (2013). doi:10.1101/cshperspect.a008722. PMC 3552500. PMID 23378584.
“Bcl-2 Regulates Reactive Oxygen Species Signaling and a Redox-Sensitive Mitochondrial Proton Leak in Mouse Pancreatic ß-Cells”. Endocrinology 157 (6): 2270–2281. (2016). doi:10.1210/en.2015-1964. PMID 27070098.
“Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy”. International Journal of Molecular Sciences 19 (12): 3950. (Dec 2018). doi:10.3390/ijms19123950. PMC 6321604. PMID 30544835.
“Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA”. Blood 109 (7): 3069–75. (Apr 2007). doi:10.1182/blood-2006-08-043257. PMC 1852223. PMID 17179226.
“Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells”. Nature 335 (6189): 440–2. (Sep 1988). Bibcode: 1988Natur.335..440V. doi:10.1038/335440a0. PMID 3262202.
Kaiser, U.; Schilli, M.; Haag, U.; Neumann, K.; Kreipe, H.; Kogan, E.; Havemann, K. (1996-08). “Expression of bcl-2--protein in small cell lung cancer”. Lung Cancer (Amsterdam, Netherlands) 15 (1): 31–40. doi:10.1016/0169-5002(96)00568-5. ISSN 0169-5002. PMID 8865121.
“Saving death: apoptosis for intervention in transplantation and autoimmunity”. Clinical & Developmental Immunology 13 (2–4): 273–82. (2006). doi:10.1080/17402520600834704. PMC 2270759. PMID 17162368.
Hou, Wu-Shiun; Van Parijs, Luk (2004-06). “A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells”. Nature Immunology 5 (6): 583–589. doi:10.1038/ni1071. ISSN 1529-2908. PMID 15133508.
“Apoptotic mechanisms and the synaptic pathology of schizophrenia”. Schizophrenia Research 81 (1): 47–63. (Jan 2006). doi:10.1016/j.schres.2005.08.014. PMID 16226876.
“Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides”. European Journal of Pharmaceutics and Biopharmaceutics 54 (3): 263–9. (Nov 2002). doi:10.1016/S0939-6411(02)00060-7. PMID 12445555.
Vogler, M.; Dinsdale, D.; Dyer, M. J. S.; Cohen, G. M. (2009-03). “Bcl-2 inhibitors: small molecules with a big impact on cancer therapy”. Cell Death and Differentiation 16 (3): 360–367. doi:10.1038/cdd.2008.137. ISSN 1476-5403. PMID 18806758.
“An inhibitor of Bcl-2 family proteins induces regression of solid tumours”. Nature 435 (7042): 677–81. (June 2005). Bibcode: 2005Natur.435..677O. doi:10.1038/nature03579. PMID 15902208.
“Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer”. Cancer Research 68 (7): 2321–8. (April 2008). doi:10.1158/0008-5472.can-07-5031. PMC 3159963. PMID 18381439.
Hauck, Paula; Chao, Bo H.; Litz, Julie; Krystal, Geoffrey W. (2009-04). “Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737”. Molecular Cancer Therapeutics 8 (4): 883–892. doi:10.1158/1535-7163.MCT-08-1118. ISSN 1535-7163. PMID 19372561.
“Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors”. Journal of Clinical Oncology 29 (7): 909–16. (March 2011). doi:10.1200/JCO.2010.31.6208. PMC 4668282. PMID 21282543.
“Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer”. Clinical Cancer Research 18 (11): 3163–9. (June 2012). doi:10.1158/1078-0432.CCR-11-3090. PMC 3715059. PMID 22496272.
“Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia”. Cancer Chemotherapy and Pharmacology 74 (3): 593–602. (September 2014). doi:10.1007/s00280-014-2530-9. PMID 25053389.
“Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia”. Cancer Discovery 4 (3): 362–75. (March 2014). doi:10.1158/2159-8290.CD-13-0609. PMC 3975047. PMID 24346116.
“Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia”. The New England Journal of Medicine 374 (4): 311–22. (January 2016). doi:10.1056/NEJMoa1513257. PMID 26639348.
“Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3”. Cell 116 (4): 527–40. (Feb 2004). doi:10.1016/s0092-8674(04)00162-x. PMID 14980220.
“Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening”. Journal of Medicinal Chemistry 44 (25): 4313–24. (Dec 2001). doi:10.1021/jm010016f. PMID 11728179.
“p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum”. The Journal of Cell Biology 139 (2): 327–38. (Oct 1997). doi:10.1083/jcb.139.2.327. PMC 2139787. PMID 9334338.
“Development of a high-throughput fluorescence polarization assay for Bcl-x(L)”. Analytical Biochemistry 307 (1): 70–5. (Aug 2002). doi:10.1016/s0003-2697(02)00028-3. PMID 12137781.
“Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function”. Molecular Cell 17 (3): 393–403. (Feb 2005). doi:10.1016/j.molcel.2004.12.030. PMID 15694340.
“Bim: a novel member of the Bcl-2 family that promotes apoptosis”. The EMBO Journal 17 (2): 384–95. (Jan 1998). doi:10.1093/emboj/17.2.384. PMC 1170389. PMID 9430630.
“BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members”. Molecular Endocrinology 12 (9): 1432–40. (Sep 1998). doi:10.1210/mend.12.9.0166. PMID 9731710.
“Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein”. Journal of Virology 72 (11): 8586–96. (Nov 1998). doi:10.1128/JVI.72.11.8586-8596.1998. PMC 110269. PMID 9765397.
“Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2”. Cancer Research 64 (21): 7947–53. (Nov 2004). doi:10.1158/0008-5472.CAN-04-0945. PMID 15520201.
“Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis”. Science 293 (5536): 1829–32. (Sep 2001). Bibcode: 2001Sci...293.1829P. doi:10.1126/science.1062257. PMID 11546872.
“BNIPL-2, a novel homologue of BNIP-2, interacts with Bcl-2 and Cdc42GAP in apoptosis”. Biochemical and Biophysical Research Communications 308 (2): 379–85. (Aug 2003). doi:10.1016/s0006-291x(03)01387-1. PMID 12901880.
“Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins”. Cell 79 (2): 341–51. (Oct 1994). doi:10.1016/0092-8674(94)90202-X. PMID 7954800.
“BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites”. The Journal of Biological Chemistry 275 (2): 1439–48. (Jan 2000). doi:10.1074/jbc.275.2.1439. PMID 10625696.
“Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death”. Cell 80 (2): 285–91. (Jan 1995). doi:10.1016/0092-8674(95)90411-5. PMID 7834748.
“Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis”. Nature Cell Biology 2 (1): 1–6. (Jan 2000). doi:10.1038/71316. PMID 10620799.
“Nuclear partners of Bcl-2: Bax and PML”. DNA and Cell Biology 23 (6): 351–4. (Jun 2004). doi:10.1089/104454904323145236. PMID 15231068.
“Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death”. Cell 74 (4): 609–19. (Aug 1993). doi:10.1016/0092-8674(93)90509-O. PMID 8358790.
“Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway”. The EMBO Journal 22 (14): 3580–90. (Jul 2003). doi:10.1093/emboj/cdg343. PMC 165613. PMID 12853473.
“Bcl-2 targets the protein kinase Raf-1 to mitochondria”. Cell 87 (4): 629–38. (Nov 1996). doi:10.1016/s0092-8674(00)81383-5. PMID 8929532.
“Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members”. The Journal of Biological Chemistry 277 (30): 27217–26. (Jul 2002). doi:10.1074/jbc.M202945200. PMID 12000759.
“Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria”. The Journal of Biological Chemistry 277 (16): 13430–7. (Apr 2002). doi:10.1074/jbc.M108029200. PMID 11832478.
“Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1”. Neoplasia 3 (6): 550–9. (2001). doi:10.1038/sj.neo.7900213. PMC 1506558. PMID 11774038.
“Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1”. Neoplasia 3 (1): 70–9. (2001). doi:10.1038/sj.neo.7900131. PMC 1505024. PMID 11326318.
“harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L)”. The EMBO Journal 16 (7): 1686–94. (Apr 1997). doi:10.1093/emboj/16.7.1686. PMC 1169772. PMID 9130713.
“Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function”. Molecular Biology of the Cell 11 (2): 735–46. (Feb 2000). doi:10.1091/mbc.11.2.735. PMC 14806. PMID 10679027.
“Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation”. The Journal of Biological Chemistry 279 (38): 40209–19. (Sep 2004). doi:10.1074/jbc.M404056200. PMID 15210690.
“Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis”. Science 288 (5468): 1053–8. (May 2000). Bibcode: 2000Sci...288.1053O. doi:10.1126/science.288.5468.1053. PMID 10807576.
“Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A”. The Journal of Biological Chemistry 273 (51): 34157–63. (Dec 1998). doi:10.1074/jbc.273.51.34157. PMID 9852076.
“Presenilin 1 protein directly interacts with Bcl-2”. The Journal of Biological Chemistry 274 (43): 30764–9. (Oct 1999). doi:10.1074/jbc.274.43.30764. PMID 10521466.
“Bcl-2 associates with the ras-related protein R-ras p23”. Nature 366 (6452): 274–5. (Nov 1993). Bibcode: 1993Natur.366..274F. doi:10.1038/366274a0. PMID 8232588.
“A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity”. Oncogene 19 (50): 5736–46. (Nov 2000). doi:10.1038/sj.onc.1203948. PMID 11126360.
“Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy”. Nature 390 (6658): 413–7. (Nov 1997). Bibcode: 1997Natur.390..413I. doi:10.1038/37144. PMID 9389483.
“Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria”. Neuron 43 (1): 19–30. (Jul 2004). doi:10.1016/j.neuron.2004.06.021. PMID 15233914.
“The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M”. Molecular and Cellular Biology 16 (7): 3884–92. (Jul 1996). doi:10.1128/MCB.16.7.3884. PMC 231385. PMID 8668206.

drugs.com

“Genasense (oblimersen sodium) FDA Approval Status - Drugs.com”. www.drugs.com. 2016年2月11日閲覧。

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000171791 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000057329 - Ensembl, May 2017

fda.gov

“FDA approves venetoclax for CLL or SLL, with or without 17p deletion, after one prior therapy” (英語). U.S. Food and Drug Administration. 2020年5月4日閲覧。

harvard.edu

ui.adsabs.harvard.edu

“Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation”. Science 226 (4678): 1097–9. (Nov 1984). Bibcode: 1984Sci...226.1097T. doi:10.1126/science.6093263. PMID 6093263.
PDB: 1G5M; “Solution structure of the antiapoptotic protein bcl-2”. Proceedings of the National Academy of Sciences of the United States of America 98 (6): 3012–7. (March 2001). Bibcode: 2001PNAS...98.3012P. doi:10.1073/pnas.041619798. PMC 30598. PMID 11248023.
“Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells”. Nature 335 (6189): 440–2. (Sep 1988). Bibcode: 1988Natur.335..440V. doi:10.1038/335440a0. PMID 3262202.
“An inhibitor of Bcl-2 family proteins induces regression of solid tumours”. Nature 435 (7042): 677–81. (June 2005). Bibcode: 2005Natur.435..677O. doi:10.1038/nature03579. PMID 15902208.
“Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis”. Science 293 (5536): 1829–32. (Sep 2001). Bibcode: 2001Sci...293.1829P. doi:10.1126/science.1062257. PMID 11546872.
“Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis”. Science 288 (5468): 1053–8. (May 2000). Bibcode: 2000Sci...288.1053O. doi:10.1126/science.288.5468.1053. PMID 10807576.
“Bcl-2 associates with the ras-related protein R-ras p23”. Nature 366 (6452): 274–5. (Nov 1993). Bibcode: 1993Natur.366..274F. doi:10.1038/366274a0. PMID 8232588.
“Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy”. Nature 390 (6658): 413–7. (Nov 1997). Bibcode: 1997Natur.390..413I. doi:10.1038/37144. PMID 9389483.